GGrantIndex
← Search

PROLEASE HGH MONTHLY IN CHILDREN W GROWTH FAILURE DUE TO GROWTH HORMONE DEFICIENC

$0M01FY2000RRNIH

University Of Virginia Charlottesville, Charlottesville VA

Investigators

Linked publications & trials

Abstract

This is a long-term multicenter, open-label study of the safety and efficacy of the new sustained release formulation of recombinant human growth hormone (rhGH), Prolease hGH, administered monthly in children with growth failure due to growth hormone deficiency. A maximum of 24 currently treated and 36 naive prepubertal GH-deficient subjects will be enrolled in this study.

View original record on NIH RePORTER →